Polypeptides for use in the Prophylactic Treatment of Allergic Asthma

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20150182620A1
SERIAL NO

14408003

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a polypeptide derived from a mite allergen (Der p 2) useful for the prophylactic treatment of allergic asthma.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITE DE NANTES1 QUAI DE TOURVILLE NANTES 44000
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C N R S)3 RUE MICHEL ANGE PARIS 75016
MEDIZINISCHE UNIVERSITAET WIENSPITALGASSE 23 VIENNA A-1090
INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE101 RUE DE TOLBIAC PARIS 75013
CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES5 ALLÉE DE I'ILE GLORIETTE NANTES CEDEX 1 44093

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Lair, David Nantes Cedex 1, FR 2 0
Magnan, Antoine Nantes Cedex 1, FR 9 1
Vrtala, Susanne Vienna, AT 23 54

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation